This financing is expected to support 2024 filing of New Drug Applications forNRX-100 (ketamine) and NRX-101 and to support launch…
AbbVie, Astellas, Eikon, Merck, Moderna, Roche, and more share new ideas to advance drug development PLEASANTON, Calif., Aug. 13, 2024…
NEW YORK, Aug. 13, 2024 /PRNewswire/ -- Inc. magazine revealed today that Acclinate has ranked No. 539 on its 2024…
Leapcure enhances clinical trials and affordable patient recruitment with strategic acquisition of Honeybee Trials.REDWOOD CITY, CA / ACCESSWIRE / August…
Regional Cancer Care Associates is pleased to announce the recognition of John Theurer Cancer Center as the #1 Cancer Program…
Aptevo's lead candidate APVO436 (mipletamig) to be evaluated in combination with standard of care venetoclax and azacitidineCompany anticipates new data…
The combined net Q2 2024 revenue of approximately $2.72 million for prescription and non-prescription products increased approximately 16% versus net…
CARMEL, Ind., Aug. 13, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology…
The ISO 13485 certification is a validation of the Company’s robust quality systemBRAINTREE, Mass., Aug. 13, 2024 (GLOBE NEWSWIRE) --…
Data from pivotal DETECT-Trial evaluating macimorelin for the diagnosis of childhood-onset growth hormone…